JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB246808

Anti-Tau Alzheimer’s Disease 抗体 [GT-38] - Conformation-Specific

Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific

Be the first to review this product! Submit a review

|

(10 Publications)

Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (ab246808) is a mouse monoclonal antibody detecting Tau Alzheimer’s Disease in IHC-P, IHC-Fr, ELISA. Suitable for Human.

別名を表示する

MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau

5 Images
Immunohistochemistry (Frozen sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
  • IHC-Fr

Lab

Immunohistochemistry (Frozen sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)

IHC image of Tau Alzheimer's Disease staining in a section of frozen human Alzheimer brain performed on a Leica BONDTM system using the standard protocol F. The section was incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunohistochemistry paraffin embedded sections - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
  • IHC-P

Collaborator

Immunohistochemistry paraffin embedded sections - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)

GT-38 detects Alzheimer's disease (AD) tau pathology. Immunofluorescence staining with GT-38 (green) at 2 μg/mL followed by anti mouse-488 conjugated secondary detection antibody in 6 μm thick sections of paraffin embedded human AD hippocampus fixed in ethanol. Blue stain is DAPI positive nuclei.

This data and image were courteously provided by Dr. Garrett Gibbons, University of Pennsylvania

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)

IHC image of Tau Alzheimer's Disease staining in a section of formalin-fixed paraffin-embedded human Alzheimer brain performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)

IHC image of Tau Alzheimer's Disease staining in a section of formalin-fixed paraffin-embedded human normal brain performed on a Leica BONDTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab246808, 1ug/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset secondary-only control image is taken from an identical assay without primary antibody.

For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

ELISA - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)
  • ELISA

Supplier Data

ELISA - Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (AB246808)

GT-38 ELISA selectively detects AD-tau compared to tau monomer. GT-38 immobilized antibody selectively captures pathological tau derived from human AD brain tissue compared to recombinant tau monomer. GT-38 captured AD-tau antigens are detected with total tau rabbit polyclonal antibodies followed by HRP-conjugated anti-rabbit secondary and colorimetric readout. Total tau ELISA serves as a loading control demonstrating equivalent loading of total tau protein from both AD-tau and tau monomer.

Purified GT-38 mouse IgG1 antibody was coated on a 384 well plate at 450 ng/well (30 uL of 15 ng/uL) in 0.1 M NaHCO3 pH 9.6 at 4°C overnight. Plates were washed with PBST (phosphate buffered saline pH 7.2 with 0.05% Tween20) five times. GT-38 capture antibody was blocked with a commercial blocking solution 4°C overnight. Antigens consisted of either human brain derived insoluble tau enriched extract (AD-tau) or purified recombinant tau monomer. AD-tau was sonicated with a probe sonicator and antigens diluted in 0.2% BSA in PBS and applied to immobilized GT-38 and allowed to incubate 4°C overnight. Plates were washed with PBST five times. Rabbit polyclonal total tau detection antibody was diluted to 3.7 μg/mL in Buffer C (20 mM sodium phosphate pH 7.0, 2 mM EDTA, 400 mM sodium chloride, 1% BSA, 0.005% thimerosal), 30 μL was added to each well and incubated for 1 hour at room temperature. Plates were washed with PBST five times. Anti-rabbit HRP conjugated was diluted 1 : 3,000 in Buffer C, 30 μL was added to each well and incubated for 1 hour at RT. Plates were washed with PBST five times. Colorimetric HRP substrate (30 μL/well) was added to the plate and developed at RT for 10 minutes. The reaction was quenched with addition of 30 μL/well 10% H2PO4 and the absorbance was measured at wavelength 450 nm.

This data and image were courteously provided by Dr. Garrett Gibbons, University of Pennsylvania.

関連する標識済み抗体及び組成の異なる製品 (5)

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-Tau Alzheimer's Disease antibody [GT-38] - Conformation-Specific

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific

  • Carrier free

    Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific - BSA and Azide free

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

GT-38

アイソタイプ

IgG1

軽鎖のタイプ

kappa

キャリアフリー

No

交差種

Human

アプリケーション

ELISA, IHC-P, IHC-Fr

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p>GT-38 works as a capture antibody but we have not had success using it as a detection antibody and have not explored extensive antibody sandwich partner compatibility.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>" } } }

製品の詳細

What is this antibody validated in?
Anti-Tau Alzheimer’s Disease antibody [GT-38] - Conformation-Specific (ab246808) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), ELISA in Human samples.

Other related products
We have a range of other formats of antibody clone [GT-38] also available for your convenience: ab246808, Carrier free - ab254274, Alexa Fluor® 488 - ab317594, Alexa Fluor® 594 - ab317763, Alexa Fluor® 647 - ab317764, Alexa Fluor® 555 - ab320065

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
バッファー組成
Preservative: 0.02% Sodium azide Constituents: PBS, 6.97% L-Arginine
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Tau protein also known as MAPT (Microtubule-Associated Protein Tau) plays a mechanical role in stabilizing microtubules in neuronal axons. The human tau protein has several isoforms generally weighing between 45 to 65 kDa. Tau is predominantly expressed in neurons of the central nervous system but can also be found in some non-neuronal cells. In neurons tau binds to tubulin and facilitates the polymerization and stability of microtubules which are essential for maintaining cellular structure and transport functions.
Biological function summary

Tau protein impacts the dynamics of the neuronal cytoskeleton. Tau is part of the intracellular transport system where it facilitates the movement of organelles and proteins along axons. This function is essential for neuron communication and resilience. Tau interacts with and regulates microtubule-associated complexes ensuring efficient intracellular transport. Its role in cytoskeletal integrity strongly influences cell signaling pathways critical for synaptic plasticity and neuronal survival.

Pathways

Tau protein plays a significant part in cellular transport and signal transduction pathways. One key pathway is the MAPK signaling pathway where tau's phosphorylation state influences neuronal response to external stimuli. Additionally tau is involved in the PI3K/AKT pathway affecting cell growth and survival. Within these pathways tau's phosphorylation is regulated by kinases including GSK-3Β and CDK5 while phosphatases like PP2A dephosphorylate tau to maintain its functional state.

Dysfunctional tau is strongly linked to neurodegenerative diseases particularly Alzheimer's disease (AD) and frontotemporal dementia (FTD). In AD hyperphosphorylated tau forms neurofibrillary tangles which disrupt neuronal function and promote cell death. This process often involves other proteins such as beta-amyloid which exacerbate tau's pathological aggregation. Understanding tauopathy mechanisms has guided the research and development of anti-tau antibodies like anti-GT3 and anti-conformation antibodies as therapeutic strategies against tau-related pathologies in neurodegenerative disorders.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
See full target information MAPT

文献 (10)

Recent publications for all applications. Explore the full list and refine your search

Alzheimer's & dementia : the journal of the Alzheimer's Association 20:8758-8768 PubMed39439289

2024

Microscopy assessment of a fluorescence [F] flortaucipir analog (T726) shows neuropathological overlap with 3R and 4R tau lesions.

Applications

Unspecified application

Species

Unspecified reactive species

Rodolfo G Gatto,Youssef Hossam,R Ross Reichard,Val J Lowe,Jennifer L Whitwell,Keith A Josephs

Acta neuropathologica communications 12:94 PubMed38867338

2024

Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.

Applications

Unspecified application

Species

Unspecified reactive species

Ujjayini Ghosh,Eric Tse,Hyunjun Yang,Marie Shi,Christoffer D Caro,Feng Wang,Gregory E Merz,Stanley B Prusiner,Daniel R Southworth,Carlo Condello

Acta neuropathologica 146:31-50 PubMed37154939

2023

Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.

Applications

Unspecified application

Species

Unspecified reactive species

Matteo Manca,Heidi G Standke,Danielle F Browne,Mikayla L Huntley,Olivia R Thomas,Christina D Orrú,Andrew G Hughson,Yongya Kim,Jing Zhang,Curtis Tatsuoka,Xiongwei Zhu,Annie Hiniker,David G Coughlin,Douglas Galasko,Allison Kraus

Toxicology reports 10:87-96 PubMed36691605

2023

Detection of β-N-methylamino-l-alanine in postmortem olfactory bulbs of Alzheimer's disease patients using UHPLC-MS/MS: An autopsy case-series study.

Applications

IHC-P

Species

Human

Susanna P Garamszegi,Sandra Anne Banack,Linda L Duque,James S Metcalf,Elijah W Stommel,Paul Alan Cox,David A Davis

Cell reports 36:109325 PubMed34233183

2021

Microtubule disruption upon CNS damage triggers mitotic entry via TNF signaling activation.

Applications

Unspecified application

Species

Unspecified reactive species

Claudia S Barros,Torsten Bossing

Alzheimer's & dementia : the journal of the Alzheimer's Association 17:1554-1574 PubMed33797838

2021

Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research.

Applications

Unspecified application

Species

Unspecified reactive species

Christina M Moloney,Val J Lowe,Melissa E Murray

Brain : a journal of neurology 143:1572-1587 PubMed32390044

2020

Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.

Applications

IHC

Species

Human

John D Arena,Douglas H Smith,Edward B Lee,Garrett S Gibbons,David J Irwin,John L Robinson,Virginia M-Y Lee,John Q Trojanowski,William Stewart,Victoria E Johnson

Nature communications 11:7 PubMed31911587

2020

Transmission of tauopathy strains is independent of their isoform composition.

Applications

IHC

Species

Human

Zhuohao He,Jennifer D McBride,Hong Xu,Lakshmi Changolkar,Soo-Jung Kim,Bin Zhang,Sneha Narasimhan,Garrett S Gibbons,Jing L Guo,Michael Kozak,Gerard D Schellenberg,John Q Trojanowski,Virginia M-Y Lee

Acta neuropathologica communications 7:34 PubMed30832741

2019

Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).

Applications

IHC-P, IF

Species

Human, Human

Garrett S Gibbons,Soo-Jung Kim,John L Robinson,Lakshmi Changolkar,David J Irwin,Leslie M Shaw,Virginia M-Y Lee,John Q Trojanowski

Journal of neuropathology and experimental neurology 77:216-228 PubMed29415231

2018

Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.

Applications

sELISA, Dot, IHC-P

Species

Human, Human, Human

Garrett S Gibbons,Rachel A Banks,Bumjin Kim,Lakshmi Changolkar,Dawn M Riddle,Susan N Leight,David J Irwin,John Q Trojanowski,Virginia M Y Lee
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com